改善基于脂质的抗真菌药物治疗Candida:一个审查
Gabriel Davi Marena1,2, Alba Ruiz-Gaitán3,4, Taís Maria Bauab1
1Department of Biological Sciences, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil.
Expert opinion on drug delivery
|October 29, 2024
概括
基于脂质的纳米系统提供了一种有前途的方法来对抗日益增长的真菌感染,特别是那些由耐药的Candida菌株引起的真菌感染. 这些先进的输送系统旨在针对性和持续地释放抗真菌药物.
科学领域:
- 菌类学 菌类学是指菌类学.
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 真菌感染,特别是Candida物种的真菌感染,正在增加,COVID-19大流行和抗真菌耐药性的增加加剧了这种情况.
- 对抗真菌治疗的治疗选择有限,这在控制这些感染方面带来了重大挑战.
研究的目的:
- 审查最近基于脂质的纳米系统在抗真菌药物输送的进展.
- 评估这些纳米载体在向耐药Candida菌株和改善治疗结果方面的潜力.
主要方法:
- 关于抗真菌应用的基于脂质的纳米系统的最新科学文献的全面分析.
- 对研究的评估,重点是这些纳米材料对抗耐药性真菌病原体的表征和治疗潜力.
主要成果:
- 基于脂质的纳米系统显示出控制和持续释放抗真菌剂的潜力.
- 这些系统在专门针对耐药的Candida菌株方面表现有前途,提供了一种新的治疗策略.
结论:
- 基于脂质的纳米材料代表了治疗具有挑战性的真菌感染的有希望的替代方案,包括那些由多药耐药菌株引起的.
- 进一步的研究和临床开发对于将纳米医学创新转化为有效的患者治疗真菌疾病至关重要.
相关概念视频
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...


